Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Comments invited on risks of nanomaterials in EU

This article was originally published in Clinica

Executive Summary

The European Commission has launched a public consultation to obtain comments on the appropriateness of EU technical guidance documents for chemicals used in nanomaterials. Comments are invited on proposed modifications to the documents as put forward by the Commission's Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) and on needs for further research and development.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048236

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel